Cargando…
Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders
Non-alcoholic fatty liver disease (NAFLD) is the worldwide most common cause of chronic liver pathology, which prevalence strongly correlates with the increasing incidence of diabetes, obesity and metabolic syndrome in the general population. Simple steatosis, the earliest NAFLD stage, usually remai...
Autores principales: | Turchinovich, Andrey, Baranova, Ancha, Drapkina, Oksana, Tonevitsky, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158334/ https://www.ncbi.nlm.nih.gov/pubmed/30294278 http://dx.doi.org/10.3389/fphys.2018.01256 |
Ejemplares similares
-
Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example
por: Page, Sandra, et al.
Publicado: (2013) -
Metabolic Changes of Hepatocytes in NAFLD
por: Lu, Qianrang, et al.
Publicado: (2021) -
Transcriptome of Extracellular Vesicles: State-of-the-Art
por: Turchinovich, Andrey, et al.
Publicado: (2019) -
Lipophagy Impairment Is Associated With Disease Progression in NAFLD
por: Carotti, Simone, et al.
Publicado: (2020) -
Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease
por: Watt, Joanne, et al.
Publicado: (2022)